Sequenom Faces Suit Over Mishandled Test Data
The suit, filed Friday in the U.S. District Court for the Southern District of California, claims San Diego-based Sequenom and five executives inflated the company's stock price by making false statements about test data and results for the product.
Sequenom announced Wednesday that it could no longer rely on the test data...
Already a subscriber? Click here to login